Standout Papers

Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcin... 2009 2026 2014 2020 681
  1. Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients (2009)
    Jennifer S. Ko, Arnold H. Zea et al. Clinical Cancer Research
  2. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline (2017)
    Sam S. Chang, Bernard H. Bochner et al. The Journal of Urology
  3. Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy (2011)
    Matthew D. Galsky, Noah M. Hahn et al. Journal of Clinical Oncology

Immediate Impact

9 by Nobel laureates 12 from Science/Nature 71 standout
Sub-graph 1 of 19

Citing Papers

Current best practice for bladder cancer: a narrative review of diagnostics and treatments
2022 Standout
Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer
2022 Standout
18 intermediate papers

Works of Robert Dreicer being referenced

Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy
2011 Standout
A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy
2011
and 8 more

Author Peers

Author Last Decade Papers Cites
Robert Dreicer 2875 3731 3245 179 8.1k
Lance C. Pagliaro 2296 2008 2058 194 5.7k
Thomas Powles 2754 5003 5758 333 10.0k
Louis Lacombe 2898 2654 3366 176 7.0k
Aristotelis Bamias 2184 1875 2984 274 6.7k
Christine Théodore 5866 3797 3394 162 10.3k
Matthew I. Milowsky 3427 5240 3112 271 9.9k
Jens Bedke 3748 2693 2917 311 7.3k
Sandrine Marréaud 4712 2564 3698 145 7.4k
Joan Carles 2944 2469 2309 322 6.0k
Arnaud Méjean 3811 1944 1401 222 6.9k

All Works

Loading papers...

Rankless by CCL
2026